Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients-Reference-Cited by-同舟云学术

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

Published:2001-08 Issue:1 Volume:103 Page:1-14
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Asnis Gregory M,Hameedi Faiq A,Goddard Andrew W,Potkin Steven G,Black Donald,Jameel Mustaq,Desagani Kishore,Woods Scott W

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference64 articles.

1. Management of panic disorders;Alexander;Journal of Psychoactive Drugs,1991

2. DSM-III-R. Diagnostic and Statistical Manual of Mental Disorders, revised,1987

3. Practice guideline for the treatment of patients with panic disorder;American Journal of Psychiatry,1998

4. Panic disorder and suicidal behavior;Arnold,1995

5. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia;Bakish;Psychopharmacology Bulletin,1996

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological treatments in panic disorder in adults: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-11-28

2. Experience of clinical use of fluvoxamine for the treatment of comorbid depression in childhood and adolescence;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

3. Medications for Anxiety Disorders;Tasman’s Psychiatry;2023

4. Comparative efficacy and acceptability of antidepressants and benzodiazepines for the treatment of panic disorder: A systematic review and network meta-analysis;Asian Journal of Psychiatry;2021-06

5. Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology;Frontiers in Psychiatry;2020-11-19